Alnylam Pharmaceuticals Inc (ALNY) — Cash Flow Quality Index
Alnylam Pharmaceuticals Inc (ALNY) has a Cash Flow Quality Index of 0.88x as of December 2025. Operating cash flow of $163.56 Million is below net income of $186.42 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Alnylam Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Alnylam Pharmaceuticals Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Alnylam Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Alnylam Pharmaceuticals Inc cash flow conversion.
Annual Cash Flow Quality Index for Alnylam Pharmaceuticals Inc (2025–2025)
Year-by-year earnings quality comparison for Alnylam Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.67x | $524.08 Million | $313.75 Million | — |